Dror S. Shouval

5.7k total citations · 1 hit paper
92 papers, 2.1k citations indexed

About

Dror S. Shouval is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Dror S. Shouval has authored 92 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Genetics, 36 papers in Immunology and 30 papers in Epidemiology. Recurrent topics in Dror S. Shouval's work include Inflammatory Bowel Disease (39 papers), Microscopic Colitis (26 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). Dror S. Shouval is often cited by papers focused on Inflammatory Bowel Disease (39 papers), Microscopic Colitis (26 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). Dror S. Shouval collaborates with scholars based in Israel, United States and United Kingdom. Dror S. Shouval's co-authors include Charles A. Dinarello, Emanuela Cagnano, Yoichiro Iwakura, Ron N. Apte, Elena Voronov, Daniel Benharroch, Yakov Krelin, Paul A. Rufo, Scott B. Snapper and Christoph Klein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Dror S. Shouval

84 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-1 is required for tumor invasiveness and angiogenesis

2003 814 citations Dror S. Shouval et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dror S. Shouval Israel	19	882	727	539	423	349	92	2.1k
Haluk Barbaros Oral Türkiye	27	496 0.6×	673 0.9×	350 0.6×	276 0.7×	424 1.2×	96	2.1k
Edwin F. de Zoeten United States	24	1.3k 1.5×	1.3k 1.8×	490 0.9×	540 1.3×	267 0.8×	59	2.9k
Hisashi Narahara Japan	33	1.2k 1.4×	957 1.3×	293 0.5×	337 0.8×	441 1.3×	194	3.4k
Atsuhiro Ogaẃa Japan	19	1.2k 1.4×	591 0.8×	524 1.0×	380 0.9×	296 0.8×	56	2.3k
Αthanasia Mouzaki Greece	30	932 1.1×	659 0.9×	202 0.4×	338 0.8×	514 1.5×	128	2.8k
Eva Rath Germany	23	437 0.5×	979 1.3×	326 0.6×	274 0.6×	284 0.8×	42	2.2k
Aude Bressenot France	22	472 0.5×	1.0k 1.4×	792 1.5×	317 0.7×	661 1.9×	48	2.5k
Sándor Sipka Hungary	34	1.1k 1.3×	474 0.7×	363 0.7×	249 0.6×	497 1.4×	188	3.3k
Jeng‐Hsien Yen Taiwan	29	1.3k 1.5×	556 0.8×	223 0.4×	368 0.9×	234 0.7×	132	2.7k
Svend T. Rietdijk Netherlands	16	1.5k 1.7×	558 0.8×	356 0.7×	259 0.6×	383 1.1×	30	2.5k

Countries citing papers authored by Dror S. Shouval

Since Specialization

Citations

This map shows the geographic impact of Dror S. Shouval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror S. Shouval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror S. Shouval more than expected).

Fields of papers citing papers by Dror S. Shouval

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror S. Shouval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror S. Shouval. The network helps show where Dror S. Shouval may publish in the future.

Co-authorship network of co-authors of Dror S. Shouval

This figure shows the co-authorship network connecting the top 25 collaborators of Dror S. Shouval. A scholar is included among the top collaborators of Dror S. Shouval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dror S. Shouval. Dror S. Shouval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guz‐Mark, Anat, Noam Zevit, Orith Waisbourd‐Zinman, et al.. (2025). Long‐term laboratory follow‐up is essential in pediatric patients with celiac. Journal of Pediatric Gastroenterology and Nutrition. 80(5). 816–823.

Schvimer, Michael, Jeffrey D. Goldsmith, Manar Matar, et al.. (2024). Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis. Journal of Pediatric Gastroenterology and Nutrition. 79(3). 501–509. 2 indexed citations

Tal, Noa, Tsachi Tsadok Perets, Manar Matar, et al.. (2024). Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition. 79(3). 564–572. 1 indexed citations

Weintraub, Yael, Anat Yerushalmy‐Feler, Esther Orlanski‐Meyer, et al.. (2024). P553 The safety and efficacy of adalimumab 80mg weekly as maintenance therapy in pediatric Crohn’s Disease. Journal of Crohn s and Colitis. 18(Supplement_1). i1081–i1081. 1 indexed citations

Shaoul, Ron, Raffi Lev‐Tzion, Michael Wilschanski, et al.. (2023). Infantile-onset inflammatory bowel disease has variable long-term outcomes. Frontiers in Pediatrics. 11. 1097779–1097779. 2 indexed citations

Fidalgo, Catarina, A Walsh, Michel Adamina, et al.. (2023). OP19 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey. Journal of Crohn s and Colitis. 17(Supplement_1). i26–i27. 2 indexed citations

Atia, Ohad, Raffi Lev‐Tzion, Richard I. Stein, et al.. (2023). P774 Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study. Journal of Crohn s and Colitis. 17(Supplement_1). i904–i905. 2 indexed citations

Egozi, Adi, Lael Werner, Richard W. Pierce, et al.. (2023). Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. PLoS Biology. 21(5). e3002124–e3002124. 21 indexed citations

Ungar, Bella, Miri Yavzori, Ella Fudim, et al.. (2022). Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD. Gut. 71(10). 1988–1997. 5 indexed citations

10.

Atia, Ohad, Eric I. Benchimol, Shira Greenfeld, et al.. (2022). Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study. Clinical Gastroenterology and Hepatology. 21(10). 2639–2648.e6. 12 indexed citations

11.

Feferman, Tali, David Morgenstern, Yaniv Lustig, et al.. (2021). Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern. Cell Reports. 37(11). 110114–110114. 33 indexed citations

12.

Shouval, Dror S.. (2021). α4β7 expression guides B cells to front lines of defense in the gut. Mucosal Immunology. 15(2). 192–194. 5 indexed citations

13.

Toothaker, Jessica M., Collin C. McCourt, Lael Werner, et al.. (2021). CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants. The Journal of Experimental Medicine. 218(9). 28 indexed citations

14.

Levi-Galibov, Oshrat, Hagar Lavon, Meirav Pevsner‐Fischer, et al.. (2020). Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer. Nature Communications. 11(1). 6245–6245. 67 indexed citations

15.

Huynh, Hien Q., Lorenzo Norsa, Séamus Hussey, et al.. (2020). Infliximab in young paediatric IBD patients: it is all about the dosing. European Journal of Pediatrics. 179(12). 1935–1944. 56 indexed citations

16.

Chermesh, Irit, Lael Werner, Ortal Barel, et al.. (2020). Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a Diagnosis. Frontiers in Immunology. 11. 1775–1775. 6 indexed citations

17.

Werner, Lael, Yu Nee Lee, Erez Rechavi, et al.. (2020). Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD. Frontiers in Immunology. 11. 109–109. 10 indexed citations

18.

Shouval, Dror S., Nurith Porat, Ron Dagan, et al.. (2010). Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center. International Journal of Infectious Diseases. 14. e253–e255. 2 indexed citations

19.

Orvin, Katia, Efraim Bilavsky, Eran Weiner, Dror S. Shouval, & Jacob Amir. (2008). Successful antibiotic eradication of Streptococcus pneumoniae infection of a ventriculoatrial shunt. International Journal of Infectious Diseases. 13(3). e101–e103. 5 indexed citations

20.

Shouval, Dror S., et al.. (2008). Presentation of Perianal Group A Streptococcal Infection as Irritability Among Children. Pediatric Dermatology. 25(5). 568–570. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact